AI Article Synopsis
- Breakthrough infections (BI) post-COVID-19 vaccination have risen due to new SARS-CoV-2 variants, prompting a study on neutralizing antibodies in affected patients.
- The study found that most patients had strong resistance (90% or more) against earlier virus strains like Wuhan, Alpha, and Delta, but little to no neutralizing activity against the Omicron BA.1 variant.
- Importantly, even patients with sufficient antibodies can still experience breakthrough infections, emphasizing the need for continued precautions despite vaccination.
Article Abstract
Breakthrough infection (BI) after coronavirus disease 2019 (COVID-19) vaccination has increased owing to the emergence of novel SARS-CoV-2 variants. In this study, we analyzed the epidemiological information and possession status of neutralizing antibodies in patients with BI using SARS-CoV-2 pseudotyped viruses. Analysis of 44 specimens from patients diagnosed with COVID-19 after two or more vaccinations showed high inhibition of infection by 90% or more against the Wuhan strain and the Alpha and Delta variants of pseudotyped viruses in 40 specimens. In contrast, almost no neutralizing activity was observed against the Omicron BA.1 variant. Many patients without neutralizing activity or BI were immunosuppressed. The results of this study show that contact with an infected person can result in BI, even when there are sufficient neutralizing antibodies in the blood. Thus, sufficient precautions must be taken to prevent infection even after vaccination.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7883/yoken.JJID.2023.100 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!